[Sillanpää M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain. 2006; 129(Pt. 3): 617-624.10.1093/brain/awh72616401617]Search in Google Scholar
[Steinlein OK. Gene polymorphisms and their role in epilepsy treatment and prognosis. Naunyn Schmiedebergs Arch Pharmacol. 2010; 382(2): 109-118.10.1007/s00210-010-0531-820556360]Search in Google Scholar
[Sisodiya SM, Marini C. Genetics of antiepileptic drug resistance. Curr Opin Neurol. 2009; 22(2): 150-156.10.1097/WCO.0b013e32832923ec19532038]Search in Google Scholar
[Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, Dini G, Janigro D. RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci. 2005; 6: 61.10.1186/1471-2202-6-61124957916188027]Search in Google Scholar
[Jullien-Flores V, Dorseuil O, Romero F, Letourneur F, Saragosti S, Berger R, Tavitian A, Gacon G, Camonis JH. Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem. 1995; 270(38): 22473-22477.10.1074/jbc.270.38.224737673236]Search in Google Scholar
[Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int J Cancer. 2003; 106(5): 635-646.10.1002/ijc.1126012866021]Search in Google Scholar
[Sharma R, Singhal SS, Cheng J, Yang Y, Sharma A, Zimniak P, Awasthi S, Awasthi YC. RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes. Arch Biochem Biophys. 2001; 391(2): 171-179.10.1006/abbi.2001.239511437348]Search in Google Scholar
[Rossé C, L'Hoste S, Offner N, Picard A, Camonis J. RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J Biol Chem. 2003; 278(33): 30597-30604.10.1074/jbc.M30219120012775724]Search in Google Scholar
[Singhal SS, Yadav S, Singhal J, Awasthi YC, Awasthi S. Mitogenic and drug-resistance mediating effects of PK-Calpha require RLIP76. Biochem Biophys Res Commun. 2006; 348(2): 722-727.10.1016/j.bbrc.2006.07.118291668216890208]Search in Google Scholar
[Awasthi S, Singhal SS, Yadav S, Singhal J, Vatsyayan R, Zajac E, Luchowski R, Borvak J, Gryczynski K, Awasthi YC. A central role of RLIP76 in regulation of glycemic control. Diabetes. 2010; 59(3): 714-725.10.2337/db09-0911282864520007934]Search in Google Scholar
[Soranzo N, Kelly L, Martinian L, Burley MW, Thom M, Sali A, Kroetz DL, Goldstein DB, Sisodiya SM. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy. Epilepsia. 2007; 48(6): 674-683.10.1111/j.1528-1167.2007.00926.x17437410]Search in Google Scholar
[Leschziner GD, Jorgensen AL, Andrew T, Williamson PR, Marson AG, Coffey AJ, Middleditch C, Balding DJ, Rogers J, Bentley DR, Chadwick D, Johnson MR, Pirmohamed M. The association between polymorphisms in RLIP76 and drug response in epilepsy. Pharmacogenomics. 2007; 8(12): 1715-1722.10.2217/14622416.8.12.171518086001]Search in Google Scholar
[Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215.10.1093/nar/16.3.12153347653344216]Search in Google Scholar
[Alper OM, Erengin H, Manguoğlu AE, Bilgen T, Cetin Z, Dedeoğlu N, Lüleci G. Consanguineous marriages in the province of Antalya, Turkey. Ann Genet. 2004; 47(2): 129-138.10.1016/j.anngen.2003.09.00115183745]Search in Google Scholar
[Janigro D, Awasthi S, Awasthi YC, Sharma R, Yadav S, Singhal SS, Hallene K. RLIP76 in AED drug resistance. Epilepsia. 2007; 48(6): 1218-1219.10.1111/j.1528-1167.2007.01155_4.x17553125]Search in Google Scholar
[Sisodiya S, Thom M. Response to Janigro et al. Epilepsia. 2007; 48(6): 219-220.10.1111/j.1528-1167.2007.01155_5.x]Search in Google Scholar
[Löscher W, Klotz U, Zimprich F, Schmidt D. The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia. 2009; 50(1): 1-23.10.1111/j.1528-1167.2008.01716.x18627414]Search in Google Scholar
[Haerian BS, Roslan H, Raymond AA, Tan CT, Lim KS, Zulkifli SZ, Mohamed EH, Tan HJ, Mohamed Z. AB-CB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis. Seizure. 2010; 19(6): 339-346.10.1016/j.seizure.2010.05.00420605481]Search in Google Scholar
[Zhang C, Kwan P, Zuo Z, Baum L. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein. Life Sci. 2010; 86(23-24): 899-905.10.1016/j.lfs.2010.04.00820417647]Search in Google Scholar
[Rivers F, O'Brien TJ, Callaghan R. Exploring the possible interaction between antiepilepsy drugs and multi-drug efflux pumps; in vitro observations. Eur J Pharmacol. 2008; 598(1-3): 1-8.10.1016/j.ejphar.2008.09.01418835265]Search in Google Scholar
[Luna-Tortós C, Fedrowitz M, Löscher W. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology. 2010; 58(7): 1019-1032.10.1016/j.neuropharm.2010.01.00720080116]Search in Google Scholar
[Sánchez MB, Herranz JL, Leno C, Arteaga R, Oterino A, Valdizán EM, Nicolás JM, Adín J, Armijo JA. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy. Seizure. 2010; 19(2): 93-101.10.1016/j.seizure.2009.12.00420064729]Search in Google Scholar
[Berg AT. Identification of pharmacoresistant epilepsy. Neurol Clin. 2009; 27(4): 1003-1013.10.1016/j.ncl.2009.06.001282718319853220]Search in Google Scholar
[Viteva EI, Zahariev ZI. Pseudoresistance in patients with epilepsy characteristics and determining factors. Folia Med (Plovdiv). 2009; 51(2): 33-39.]Search in Google Scholar
[Kim WJ, Lee JH, Yi J, Cho YJ, Heo K, Lee SH, Kim SW, Kim MK, Kim KH, Lee BI, Lee MG. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet Genom. 2010; 20(4): 249-256.10.1097/FPC.0b013e328338073a20216337]Search in Google Scholar
[Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L, Malerba A, Muscas G, La Neve A, Striano P, Perucca E, and the SOPHIE Study Group. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia. 2010; 51(5): 797-804.10.1111/j.1528-1167.2010.02520.x20545754]Search in Google Scholar